Related content

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome

By Yilmaz Murat   Bi˙ri˙ Aydan   Bukan Neslihan   Karakoç Ayhan   Sancak Banu   Törüner Füsun   Paşaoğlu Hatice  

Gynecological Endocrinology, Vol. 20, Iss. 5, 2005-05 ,pp. : 258-263

Informa Healthcare

Access to resources Recommend Favorite

The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome

By Yilmaz Nafiye   Uygur Dilek   Dogan Muammer   Ozgu Emre   Salman Burcin   Mollamahmutoglu Leyla  

Gynecological Endocrinology, Vol. 28, Iss. 3, 2012-03 ,pp. : 162-165

Informa Healthcare

Access to resources Recommend Favorite

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome

By Chen Mei-Jou   Yang Wei-Shiung   Chen Hsin-Fu   Kuo Jahn-Jahn   Ho Hong-Nerng   Yang Yu-Shih   Chen Shee-Uan  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 779-785

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome

By Eldar-Geva T.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2552-2556

Oxford University Press

Access to resources Recommend Favorite

Serum total l-carnitine levels in non-obese women with polycystic ovary syndrome

By Fenkci Semin Melahat   Fenkci Veysel   Oztekin Ozer   Rota Simin   Karagenc Nedim  

Human Reproduction, Vol. 23, Iss. 7, 2008-07 ,pp. : 1602-1606

Oxford University Press

Access to resources Recommend Favorite